GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with inhibitory peptide rrgl

Analyse Crystal structure of the catalytic domain of botulinum neurotoxin serotype a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3C8A
Type
protein
Length
426 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin a light chain; Inhibitor peptide rrgl
EC
3.4.24.69
UniProt
A5HZZ9
Ligands
ZN, SO4, NH2
Pockets
5 · best druggability 0.53

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin a light chain (EC 3.4.24.69)protein42233% helix, 18% strandA5HZZ9
BInhibitor peptide rrglprotein40% helix, 0% strand—

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A, B
  • NH2 · Amino group · ion · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11780.530.7831SO4
21040.340.7322empty
3690.330.7617empty
4530.310.7714empty
5550.300.7512empty

Interfaces

1 interface between chains.

  • A–B · 513 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 3C8A · Crystal structure of the catalytic domain of botulinum neurotoxin serotype A with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.